When US pharmaceutical companies operate in Malaysia, they may encounter challenges related to currency exchange and payment delays, cultural and language barriers, as well as legal and regulatory differences. To minimize the risk of unpaid bills, it is important for these companies to establish clear payment terms and conditions, build…